Nine Chapters Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Nine Chapters Capital Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-9,800	Closed	-$343K	–	1346
2014 Q3	$343K	Buy	+9,800	New	+$336K	0.03%	666
2014 Q1	–	Sell	-8,300	Closed	-$319K	–	1068
2013 Q4	$319K	Sell	8,300 -6,700	-45%	-$212K	0.03%	595
2013 Q3	$411K	Buy	+15,000	New	+$355K	0.05%	466

Other funds holding WX

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Nine Chapters Capital Management's WX Position: Q4 2014 in Review

Nine Chapters Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2014, closing a stake of 9,800 shares — an estimated $343K sold.

Nine Chapters Capital Management first reported a position in WX in Q3 2013 and held it in 3 quarters. The position peaked at $411K in Q3 2013. 165 funds tracked by Wall St. Rank hold WX as of Q4 2014.

Nine Chapters Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2014 after selling out during the quarter.
Nine Chapters Capital Management sold 9,800 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2014, an estimated $343K.
Nine Chapters Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 3 quarters.
Nine Chapters Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $411K in Q3 2013.
165 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2014.

Based on Nine Chapters Capital Management's 13F filing for Q4 2014, filed 9 Feb 2015.